Gene: RPL23AP1 (ribosomal protein L23a pseudogene 1)
Homo sapiens |
| Symbol: |
RPL23AP1
|
| Name: |
ribosomal protein L23a pseudogene 1
|
| Description: |
INTERACTS WITH 5-fluorouracil |
| Type: |
pseudo
|
| RefSeq Status: |
INFERRED
|
| Also known as: |
dJ377H14.8; RPL23A_15_676
|
| Related Functional Gene: |
RPL23A
|
| Latest Assembly: |
Human Genome Assembly GRCh37
|
| Position: |
| Map | Chr | Position | Strand | Source |
|---|
Human Alternate Assembly CHM1_1 | 6 | 29,612,425 - 29,612,947 | - | NCBI | Human Genome Assembly HuRef | 6 | 29,498,069 - 29,498,591 | - | NCBI | Human Genome Assembly GRCh37 | 6 | 29,694,409 - 29,694,931 | - | NCBI | Human Celera Assembly | 6 | 31,297,838 - 31,298,360 | - | NCBI | Human Genome Assembly Build 36 | 6 | 29,802,325 - 29,802,995 | - | NCBI | Human Cytogenetic Map | 6 | p21.3 | | NCBI |
|
| Model |
|
|
 Gene-Chemical Interaction Annotations
References - curated References - uncurated Genomics
Position Markers
| RH71004 |
| Map | Chr | Position | Strand | Source |
|---|
Human GeneMap99-GB4 RH Map | 6 | 117.36 | | UniSTS | Human Genome Assembly HuRef | 6 | 29,497,896 - 29,498,143 | | UniSTS | Human Genome Assembly GRCh37 | 6 | 29,694,232 - 29,694,483 | | UniSTS | Human Celera Assembly | 6 | 31,297,661 - 31,297,912 | | RGD | Human Genome Assembly Build 36 | 6 | 29,802,211 - 29,802,462 | | RGD | Human Cytogenetic Map | 6 | p22.1 | | UniSTS | Human Cytogenetic Map | 6 | p21.3 | | UniSTS |
|
| STS-R00280 |
| Map | Chr | Position | Strand | Source |
|---|
Human NCBI RH Map | 6 | 469.3 | | UniSTS | Human GeneMap99-GB4 RH Map | 6 | 116.32 | | UniSTS | Human Genome Assembly HuRef | 6 | 29,497,762 - 29,497,912 | | UniSTS | Human Genome Assembly GRCh37 | 6 | 29,694,098 - 29,694,248 | | UniSTS | Human Celera Assembly | 6 | 31,297,527 - 31,297,677 | | RGD | Human Genome Assembly Build 36 | 6 | 29,802,077 - 29,802,227 | | RGD | Human Cytogenetic Map | 6 | p22.1 | | UniSTS | Human Cytogenetic Map | 6 | p21.3 | | UniSTS |
|
| D6S2866 |
| Map | Chr | Position | Strand | Source |
|---|
Human Genome Assembly HuRef | 6 | 29,497,899 - 29,498,106 | | UniSTS | Human Genome Assembly GRCh37 | 6 | 29,694,235 - 29,694,446 | | UniSTS | Human Celera Assembly | 6 | 31,297,664 - 31,297,875 | | RGD | Human Genome Assembly Build 36 | 6 | 29,802,214 - 29,802,425 | | RGD | Human Cytogenetic Map | 6 | p22.1 | | UniSTS | Human Cytogenetic Map | 6 | p21.3 | | UniSTS |
|
| HLA-F |
| Map | Chr | Position | Strand | Source |
|---|
Human Genome Assembly HuRef | 6 | 29,497,896 - 29,498,143 | | UniSTS | Human Genome Assembly HuRef | 6 | 29,497,889 - 29,498,143 | | UniSTS | Human Genome Assembly GRCh37 | 6 | 29,694,232 - 29,694,483 | | UniSTS | Human Genome Assembly GRCh37 | 6 | 29,694,225 - 29,694,483 | | UniSTS | Human Celera Assembly | 6 | 31,297,654 - 31,297,912 | | RGD | Human Celera Assembly | 6 | 31,297,661 - 31,297,912 | | UniSTS | Human Genome Assembly Build 36 | 6 | 29,802,204 - 29,802,462 | | RGD | Human Cytogenetic Map | 6 | p21.3 | | UniSTS | Human Cytogenetic Map | 6 | p22.1 | | UniSTS |
|
QTLs in Region (Human Genome Assembly GRCh37)
| 1357312 | AASTH11_H | Allergic/atopic asthma related QTL 11 (human) | 1.45 | | Reversible airflow obstruction | ETS negative | 6 | 7409390 | 40597971 | Human | | 2316062 | GLUCO205_H | Glucose level QTL 205 (human) | | .009 | Glucose level | | 6 | 11185969 | 37185969 | Human | | 1357330 | AASTH22_H | Allergic/atopic asthma related QTL 22 (human) | 1.91 | .003 | Reversible airflow obstruction | post-bronchodilator FEV1 | 6 | 12297121 | 38297121 | Human | | 2301165 | PRSTS379_H | Prostate tumor susceptibility QTL 379 (human) | | | Prostate tumor susceptibility | | 6 | 12297121 | 38297121 | Human | | 2314565 | GLUCO50_H | Glucose level QTL 50 (human) | 1 | | Glucose level | | 6 | 13073821 | 39073821 | Human | | 2289164 | BW111_H | Body weight QTL 111 (human) | | .002 | Body fat amount | percent fat | 6 | 18540451 | 44540451 | Human | | 2289194 | BW353_H | Body weight QTL 353 (human) | | .012 | Body fat amount | percent fat | 6 | 18540451 | 44540451 | Human | | 2289175 | BW112_H | Body weight QTL 112 (human) | | .048 | Body fat amount | percent fat | 6 | 18683815 | 44683815 | Human | | 1358839 | MULTSCL5_H | Multiple sclerosis susceptibility QTL 5 (human) | | | Multiple sclerosis susceptibility | | 6 | 19552079 | 45552079 | Human | | 1358857 | MULTSCL19_H | Multiple sclerosis susceptibility QTL 19 (human) | | | Multiple sclerosis susceptibility | | 6 | 19552079 | 45552079 | Human | | 1559135 | LDLPS2_H | Low density lipoprotein particle size QTL 2 (human) | 4.1 | | LDL particle size | | 3 | 23001248 | 49001248 | Human | | 1357292 | AASTH34_H | Allergic/atopic asthma related QTL 34 (human) | 2.61 | | Atopy | reversible airflow obstruction | 6 | 23265619 | 49265619 | Human | | 2289170 | BW113_H | Body weight QTL 113 (human) | | .018 | Body fat amount | percent fat | 6 | 23265619 | 49265619 | Human | | 2314583 | GLUCO43_H | Glucose level QTL 43 (human) | 1.2 | | Glucose level | | 6 | 23313896 | 41677354 | Human | | 1298431 | RA11_H | Rheumatoid arthritis QTL 11 (human) | | .0000024 | Joint/bone inflammation | rheumatoid arthritis | 6 | 23773378 | 36265722 | Human | | 2292786 | PRSTS7_H | Prostate tumor susceptibility QTL 7 (human) | | | Prostate tumor susceptibility | late onset | 6 | 28677275 | 54677275 | Human | |
